• Maria V DE LA Torre-Prados, Angela Garcia-DE LA Torre, Alfredo Enguix, Maria Mayor-Reyes, María Nieto-González, and Angel Garcia-Alcantara.
• Department of Intensive Care Medicine, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Malaga University, Malaga, Spain - mariav.torre.sspa@juntadeandalucia.es.
• Minerva Anestesiol. 2016 Jul 1; 82 (7): 760-6.

BackgroundThe aim was to ascertain the prognostic value of mid-regional pro-adrenomedullin (MR-proADM), measured within 24 hours from the onset of septic shock (SS).MethodsWe performed a prospective, observational study on all patients admitted to our hospital's Intensive Care Unit with SS over a one year period from January to December 2011 to examine the outcomes in 100 consecutive SS cases. Demographic data and severity score (APACHEII and SOFA) were recorded. MR-proADM, C-reactive protein and procalcitonin were measured within the first 24 hours from SS onset. The outcome variable studied was 28-day mortality. Data were evaluated with non-parametric statistics bivariant and multivariate analyses for survival analysis.ResultsIn patients who died within 28 days (36%), MR-proADM, Lactate, APACHE II as well as SOFA were significantly higher compared with survivors. MR-proADM showed the best association with 28-day mortality, as well as a prognostic value (logrank test: P=0.0012). Statistical significance was also seen in the Cox regression analysis (P=0.0004) for all patients with a Relative Risk of 1.26 times that of the baseline for each mmol/L of increase in MR-proADM.ConclusionsIn our study MR-proADM levels measured on admission correlates with 28-day mortality in patients with septic shock.

18 keywords...

hide…